Latest news from Perelman School of Medicine at the University of Pennsylvania on Newswise en-us Copyright 2025 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/penn-medicine-s-susan-domchek-md-honored-by-asco-for-cancer-prevention-work/?sc=rsin /articles/penn-medicine-s-susan-domchek-md-honored-by-asco-for-cancer-prevention-work/?sc=rsin Thu, 30 Jan 2025 20:00:09 EST Susan M. Domchek, MD, FASCO, has been recognized by the American Society of Clinical Oncology (ASCO) with one of the society's highest honors, as the 2025 recipient of the ASCO-American Cancer Society Cancer Prevention Award. Perelman School of Medicine at the University of Pennsylvania /articles/cholesterol-test-completion-triples-when-automatically-pre-ordered/?sc=rsin /articles/cholesterol-test-completion-triples-when-automatically-pre-ordered/?sc=rsin Wed, 29 Jan 2025 18:15:21 EST Perelman School of Medicine at the University of Pennsylvania /articles/standardizing-provider-assessments-reveals-important-information-about-gun-and-opioid-access-for-veterans-at-risk-of-suicide/?sc=rsin /articles/standardizing-provider-assessments-reveals-important-information-about-gun-and-opioid-access-for-veterans-at-risk-of-suicide/?sc=rsin Tue, 28 Jan 2025 11:00:00 EST Standardizing an assessment process currently used by doctors during care discussions with veterans at risk for suicide in other context could shed more light on the risks related to firearms and opioids. Perelman School of Medicine at the University of Pennsylvania /articles/penn-medicine-names-pari-v-pandharipande-chair-of-radiology/?sc=rsin /articles/penn-medicine-names-pari-v-pandharipande-chair-of-radiology/?sc=rsin Wed, 22 Jan 2025 20:30:50 EST Pari V. Pandharipande, MD, MPH, FACR, a nationally renowned physician-scientist at The Ohio State University (OSU) College of Medicine and Wexner Medical Center, has been named Chair of the department of Radiology at Penn Medicine, effective June 1, 2025. Perelman School of Medicine at the University of Pennsylvania /articles/penn-medicine-scientists-develop-tiny-anticancer-weapon/?sc=rsin /articles/penn-medicine-scientists-develop-tiny-anticancer-weapon/?sc=rsin Wed, 15 Jan 2025 20:45:59 EST A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University of Pennsylvania. Perelman School of Medicine at the University of Pennsylvania /articles/ai-tool-analyzes-30k-data-points-per-medical-imaging-pixel-in-cancer-search/?sc=rsin /articles/ai-tool-analyzes-30k-data-points-per-medical-imaging-pixel-in-cancer-search/?sc=rsin Wed, 15 Jan 2025 05:00:00 EST A new AI tool can search through data and histology images for exponentially more precise information on cancer treatment effectiveness than what can be gleaned from CT or MRI scans Perelman School of Medicine at the University of Pennsylvania /articles/using-ai-to-uncover-hospital-patients-long-covid-care-needs/?sc=rsin /articles/using-ai-to-uncover-hospital-patients-long-covid-care-needs/?sc=rsin Fri, 10 Jan 2025 20:05:50 EST A new machine learning technique could help inform clinical decision-making across hospital systems to address the challenges of long COVID-19 care. Perelman School of Medicine at the University of Pennsylvania /articles/penn-medicine-launches-a-pioneering-project-to-study-the-human-virome-puzzle/?sc=rsin /articles/penn-medicine-launches-a-pioneering-project-to-study-the-human-virome-puzzle/?sc=rsin Thu, 09 Jan 2025 22:05:06 EST Researchers at the Perelman School of Medicine at the University of Pennsylvania have set out to identify, quantify, and classify the many viruses living in our bodies so that future research can uncover how they affect human health. Perelman School of Medicine at the University of Pennsylvania /articles/science-behind-genetic-testing-for-identifying-risk-of-opioid-misuse-remains-unproven/?sc=rsin /articles/science-behind-genetic-testing-for-identifying-risk-of-opioid-misuse-remains-unproven/?sc=rsin Thu, 09 Jan 2025 11:00:00 EST Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for OUD in 2022. Efforts to ease the crisis have included the development of genetic testing to identify individuals most at risk for OUD. Perelman School of Medicine at the University of Pennsylvania /articles/a-right-heart-exceeds-all-new-cares-grants-behind-penn-medicine-volunteer-projects/?sc=rsin /articles/a-right-heart-exceeds-all-new-cares-grants-behind-penn-medicine-volunteer-projects/?sc=rsin Thu, 09 Jan 2025 08:45:02 EST The foundation of health care is strengthened by those who deliver that care, particularly by those who supplement their work through voluntary action. 37 Penn Medicine staff and medical students used Penn Medicine CAREs grants to serve their communities and beyond, from distributing warm clothes and food to helping young people who have been impacted by HIV/AIDS. Perelman School of Medicine at the University of Pennsylvania /articles/distributing-disposal-kits-increase-amount-of-leftover-opioids-trashed/?sc=rsin /articles/distributing-disposal-kits-increase-amount-of-leftover-opioids-trashed/?sc=rsin Mon, 06 Jan 2025 16:20:03 EST Perelman School of Medicine at the University of Pennsylvania /articles/maternal-workplace-health-companies-get-penn-medicine-wharton-funds/?sc=rsin /articles/maternal-workplace-health-companies-get-penn-medicine-wharton-funds/?sc=rsin Thu, 02 Jan 2025 08:55:51 EST Two new companies will each receive a $250,000 investment from the Penn Medicine-Wharton Fund for Health: Cayaba Care, a maternal health start-up, and On the Goga, a workplace well-being company. Perelman School of Medicine at the University of Pennsylvania /articles/discovery-links-cellular-structures-to-kidney-cancer-treatment-outcomes/?sc=rsin /articles/discovery-links-cellular-structures-to-kidney-cancer-treatment-outcomes/?sc=rsin Thu, 02 Jan 2025 08:00:27 EST Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to explain why. Perelman School of Medicine at the University of Pennsylvania /articles/multimodal-spatial-profiling-reveals-immune-suppression-and-microenvironment-remodeling-in-fallopian-tube-precursors-to-high-grade-serous-ovarian-carcinoma/?sc=rsin /articles/multimodal-spatial-profiling-reveals-immune-suppression-and-microenvironment-remodeling-in-fallopian-tube-precursors-to-high-grade-serous-ovarian-carcinoma/?sc=rsin Mon, 23 Dec 2024 18:30:34 EST Perelman School of Medicine at the University of Pennsylvania /articles/generic-platinum-chemotherapy-shortages-did-not-increase-deaths/?sc=rsin /articles/generic-platinum-chemotherapy-shortages-did-not-increase-deaths/?sc=rsin Fri, 13 Dec 2024 17:45:50 EST An analysis of national data found that short-term mortality was not impacted for patients with advanced cancers during the shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023. Perelman School of Medicine at the University of Pennsylvania /articles/keto-diet-metabolite-may-power-up-car-t-cells-to-kill-cancer/?sc=rsin /articles/keto-diet-metabolite-may-power-up-car-t-cells-to-kill-cancer/?sc=rsin Sat, 07 Dec 2024 10:15:00 EST A simple dietary supplement may provide a new approach to boost CAR T cell function, according to a study from researchers in the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center, presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition (Abstract 4). Perelman School of Medicine at the University of Pennsylvania /articles/penn-medicine-partners-with-mark-cuban-s-cost-plus-drugs/?sc=rsin /articles/penn-medicine-partners-with-mark-cuban-s-cost-plus-drugs/?sc=rsin Fri, 06 Dec 2024 10:40:10 EST Penn Medicine has partnered with Mark Cuban's Cost Plus Drug Company through its innovative Cost Plus Marketplace in a strategic alliance that will allow Penn Medicine to secure the top 100 most frequently dispensed generic drugs--such as antibiotics, cancer treatments, blood thinners, and asthma medications--from the company for the health system's vast retail pharmacy network, which fills over 1.5 million prescriptions annually across 16 locations. Perelman School of Medicine at the University of Pennsylvania /articles/online-health-care-reviews-turned-negative-following-covid-pandemic/?sc=rsin /articles/online-health-care-reviews-turned-negative-following-covid-pandemic/?sc=rsin Mon, 25 Nov 2024 11:30:44 EST Researchers showed online reviews of health facilities took a negative turn after COVID and remain that way Perelman School of Medicine at the University of Pennsylvania /articles/university-of-pennsylvania-health-system-releases-sweeping-climate-and-sustainability-action-plan/?sc=rsin /articles/university-of-pennsylvania-health-system-releases-sweeping-climate-and-sustainability-action-plan/?sc=rsin Mon, 18 Nov 2024 15:25:23 EST Following an Earth Day pledge to significantly reduce the organization's environmental footprint by 2050, the University of Pennsylvania Health System (UPHS) announced its Climate and Sustainability Action Plan (CSAP), an ambitious strategy to halve emissions by 2030, and eliminate them by 2042, underscoring the goal to become the nation's most environmentally friendly health care organization. Perelman School of Medicine at the University of Pennsylvania /articles/penn-study-highlights-inconsistencies-of-genetic-markers-for-predicting-heart-disease/?sc=rsin /articles/penn-study-highlights-inconsistencies-of-genetic-markers-for-predicting-heart-disease/?sc=rsin Sat, 16 Nov 2024 14:30:00 EST Polygenic risk scores (PRSs) are a cutting-edge tool in genetics, combining information from genetic markers across the genome to estimate a person's risk of developing certain diseases, such as coronary artery disease (CAD). By analyzing a person's DNA, PRSs offer insights into an individual's genetic predisposition for conditions like heart disease, potentially informing a more personalized approach to healthcare. But there can be significant variability across currently available PRSs, which may limit their reliability for individual predictions, according to new research from the Perelman School of Medicine at the University of Pennsylvania published this week in JAMA and presented at the American Heart Association's Scientific Sessions in Chicago. Perelman School of Medicine at the University of Pennsylvania